HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform

This article was originally published in The Rose Sheet

Executive Summary

Senator Orrin Hatch, R-Utah, introduces the FDA Cosmetic Safety and Modernization Act with the Personal Care Products Council's backing. The Environmental Working Group is opposed to the proposal, which falls considerably short of the draft Personal Care Products Safety Act, but the bill could unite big and small business, which were divided in the previous Congress with respect to regulatory reform legislation.

Advertisement

Related Content

California’s Toxic Free Cosmetics Act And The Case For Iconclad Federal Preemption
Congressional Races Could Alter Cosmetics Legislative Outlook, Starting With House Energy & Commerce
‘California’s A Problem,’ But Prop 65 Preemption For Cosmetics Could Be Out Of Reach
‘Something’s Going To Happen’: Former FDAer John Bailey On Cosmetics Reform Legislation
Cosmetics Reg Reform Ill-Situated As Trump, FDA Explore 'Burden Reduction'
Rep. Pallone Seeks Answers In Tween Makeup Asbestos Controversy
Cosmetics Provisions Unlikely To Catch Ride On FDA User-Fee Bill
PCPC Hatching Proposal For CIR Role In FDA Ingredient Review
PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises
FDA Seeks Info From Injured WEN Users, Docs As Investigation Continues

Topics

Advertisement
UsernamePublicRestriction

Register

RS121280

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel